Company intelligence / Profile preview

Clinres Farmacija

Ownership: Private
Employees: ~81
Development stage: Other

Overview

Clinres Farmacija is an established contract research organization (CRO) providing comprehensive clinical trial management and regulatory consulting services for pharmaceutical products, medical devices, food supplements, cosmetics, biocides and general goods. The company has managed over 250 clinical trials across multiple therapeutic areas in Central and Eastern Europe. In December 2023 it was acquired by ProPharma Group to expand their European footprint.

Modalities: Not directly applicable; as a CRO, the company supports clinical development for various modalities including Small molecule, Biologic, Medical device, and others
Industry: Contract Research Organization

Partnerships

ProPharma Group is the acquirer/parent company as of December 2023No other major partnerships disclosed.

Beyond the preview

Go deeper on Clinres Farmacija.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clinres Farmacija.

Explore the full profile